RedHill Biopharma (RDHL) Interest & Investment Income (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly Interest & Investment Income of $7.1 million for Q2 2023, up 326.9% year-over-year from $1.7 million in Q2 2022, and down 67.13% quarter-over-quarter from $21.6 million in Q1 2023.
RedHill Biopharma (RDHL) Interest & Investment Income (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported Interest & Investment Income for 12 consecutive years, with $7.1 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Interest & Investment Income rose 326.9% year-over-year to $7.1 million; the TTM figure through Jun 2023 stood at $40.6 million (up 2284.89% YoY), while the FY2025 annual figure was $1.3 million, down 84.21% from the prior year.
- Interest & Investment Income eased to $7.1 million in Q2 2023 per RDHL's latest filing, from $21.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $21.6 million in Q1 2023 and bottomed at -$214000.0 in Q1 2020.
- Historically, Interest & Investment Income has averaged $2.5 million across 5 years, with a median of $139000.0 in 2019.
- Annual changes were most pronounced in 2020 — Interest & Investment Income slumped 157.22% — and 2023, when it soared 215720.0%.
- RedHill Biopharma's Interest & Investment Income stood at $260000.0 in 2019, then tumbled by 126.54% to -$69000.0 in 2020, then surged by 117.39% to $12000.0 in 2021, then jumped by 72400.0% to $8.7 million in 2022, then retreated by 18.45% to $7.1 million in 2023.
- Business Quant data shows RDHL's Interest & Investment Income at $7.1 million in Q2 2023, $21.6 million in Q1 2023, and $8.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 7.10 Mn |
| Mar 31, 2023 | 21.58 Mn |
| Dec 31, 2022 | 8.70 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 1.66 Mn |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | -69,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 108,000.00 |
| Mar 31, 2020 | -214,000.00 |
| Dec 31, 2019 | 260,000.00 |
| Sep 30, 2019 | 170,000.00 |
| Jun 30, 2019 | 1.55 Mn |
| Mar 31, 2019 | 374,000.00 |
| Dec 31, 2018 | 314,000.00 |
| Sep 30, 2018 | 133,000.00 |